Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine
- 1 April 1997
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 41 (7) , 774-781
- https://doi.org/10.1016/s0006-3223(96)00207-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effects of fluoxetine and maprotilin on platelet 5-HT in depressive patientsBiological Psychiatry, 1991
- Does 24-h urinary MHPG predict treatment response to antidepressants? I. A reviewJournal of Affective Disorders, 1990
- Characteristics of patients with the highest plasma catecholamine metabolite levelsAmerican Journal of Psychiatry, 1988
- Failure of urinary MHPG levels to predict treatment response in patients with unipolar depressionAmerican Journal of Psychiatry, 1986
- Disposition and Metabolism of MHPG in Humans: Application to Studies in DepressionPharmacopsychiatry, 1984
- Relation Between Plasma and Cerebrospinal Fluid Levels of 3-Methoxy-4-HydroxyphenylglycolScience, 1983
- 3-Methoxy-4-Hydroxyphenethyleneglycol Production by Human Brain in VivoScience, 1979
- A Diagnostic InterviewArchives of General Psychiatry, 1978
- Catecholamine Metabolism, Depressive Illness, and Drug ResponseArchives of General Psychiatry, 1972
- Development of a Rating Scale for Primary Depressive IllnessBritish Journal of Social and Clinical Psychology, 1967